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Wednesday, February 6, 2013 557atargeting riboflavin binding protein (RFBP), which acts as a model protein for
the riboflavin receptor. By characterizing the binding interactions between ri-
boflavin dendrimer gold nanoparticle conjugates and RFBP, the efficacy of
this platform for a targeted approach of drug delivery can be predicted more
accurately. Atomic Force Microscopy (AFM) was used for biological imaging
studies of these riboflavin-dendrimer complexes conjugated with gold-
nanoparticles. using a systematic ‘‘building block’’ approach, the size distribu-
tion of riboflavin dendrimer gold nanoparticle conjugates was mapped.
Changes in height upon binding to RFBP and subsequent removal by compet-
itive binding ligands demonstrate that this method could present a novel ap-
proach to screening the binding of drugs to drug targets.
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Importin-beta plays an important role in material exchange between the cell nu-
cleus and the cytoplasm. In order to transport large molecules through the nu-
clear pore complex it has to bind tightly to the importin-beta-binding (IBB)
domain of its cargo.
To probe the mechanical properties of this binding, enforced unbinding was in-
vestigated by single molecule atomic force microscopy (AFM) experiments in
which the cargo was pulled out of the complex. To structurally characterize the
unfolding pathway, we have performed force probe molecular dynamics (MD)
simulations at different constant loading rates on the importin-beta/IBB domain
complex.
Depending on the applied loading rate, three different unbinding pathways
were observed. using time dependent rate theory, these pathways were charac-
terized in terms of the rupture rate, rupture length and the barrier height of the
complex, which allow direct comparison with AFM data.
We hypothesize that the elastic properties of the involved proteins control bind-
ing and unbinding of this complex.
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ADP-glucose pyrophosphorylase (ADP-Glc PPase) is the regulatory enzyme of
the pathway for starch synthesis in plants and glycogen in mammals and enteric
bacteria. It exists as a 200 kDa homotetramer (a4) in enteric bacteria, and as
a heterotetramer (a2b2) in plants. In both in vivo and in vitro the substrates
(Glucose 1-Phosphate; Glc-1P and Adenosine 5’-Triphosphate; ATP) are con-
verted into a glucose donor ADP-Glucose and a pyrophosphate (PPi) via the
ADP-Glc PPase enzyme. It has been noted that some residues are conserved
in homotetrameric bacterial ADP-Glc PPases, but are not in some plant forms.
One of them is Arginine-32 (R32) in the Escherichia coli ADP-Glc PPase. To
explore the overall role of this residue and evaluate the structural and electro-
static importance of the Arginine’s guanidinium group, we replaced it with Ly-
sine (K, -amino group), Alanine (A, - methyl group), Cysteine (C, -sulfide
group), Glutamic (E, - carboxylate group), Glutamine (Q, -amido group) and
Leucine (L, -hydrophobic side chain) via site directed mutagenesis. We over-
expressed the enzymes, purified them to homogeneity, and measured their ki-
netic properties. The Specific Activity (U/mg) for the mutants were as follows:
WT (90.56), R32A (1.65), R32C (0.57), R32E (0.04), R32K (5.81), R32L
(0.65) and R32Q (1.37). Currently, the properties of the R32H (Histidine, -imi-
dizoleum ring) mutant are being investigated. Our results clearly indicate that
this guanidinium group of the Arginine-32 residue is critical for catalysis. Mod-
eling of the E. coli enzyme suggests that the two (2) nitrogen atoms of the gua-
nidinium group may interact with the b and g phosphates of the ATP, helping in
the positioning of the substrates, via electrostatic interactions, and making the
PPi product a more stable leaving group.
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Ubiquitylation is a highly controlled post-translational modification of proteins,
in which proteins are conjugated either with monoubiquitin or polyubiquitin
chains. Ubiquitin modifications on target proteins are recognized by
ubiquitin-binding domains, which are found in several effector proteins. In
this study, we describe the function of the Toll-interacting protein (Tollip),which is an effector protein in the innate immune signaling pathway and an
adaptor protein for endosomal trafficking. We have previously demonstrated
that the central C2 domain of Tollip preferentially interacts with phosphoinosi-
tides and that this association is critical for membrane targeting of the protein.
Remarkably, we found that ubiquitin modulates Tollip’s lipid binding.We have
observed an ubiquitin dose-dependent inhibition of binding of Tollip to phos-
phoinositides and it does so specifically by blocking Tollip C2 domain-
phosphoinositide interactions. This led us to hypothesize that the Tollip C2 do-
main is a novel ubiquitin-binding domain. In addition, we have biophysically
characterized the association of the Tollip CUE domain to ubiquitin and iden-
tified key interacting residues. The Tollip CUE domain reversibly binds ubiq-
uitin with low micromolar affinity at a site that overlaps with that
corresponding to the Tollip C2 domain. We have also found that ubiquitin bind-
ing to dimeric Tollip CUE domain induces a drastic conformational change in
the protein, leading to the formation of a heterodimeric Tollip CUE-ubiquitin
complex. These data suggest that ubiquitin binding to the Tollip C2 and
CUE domain and ubiquitin-mediated dissociation of CUE dimer reduces the af-
finity of the Tollip protein for endosomal phosphoinositides, allowing Tollip
cytoplasmic sequestration. Overall, our findings will provide the structural
and molecular basis to understand how Tollip, as an endocytic adaptor protein,
is modulated by ubiquitin and determines the fate of polyubiquitinated cargo
for endosomal degradation.
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Maintaining membrane proteins at the right place at the right time is crucial
to cellular function. To support such organization a broad spectrum of regu-
lating proteins from the cytosol bind, recruit and arrange the membrane pro-
teins into specific structures. PICK1 is an abundant scaffolding protein
interacting with more than 30 different receptors, transporters and ion chan-
nels, embedded in lipid membranes. PICK1 contains a single N-terminal PDZ
domain and forms homodimers via its central membrane bending and curva-
ture sensing N-BAR domain thus forming a functional unit with two PDZ do-
mains. The PICK1 PDZ domain binds many different PDZ peptide ligands
such as GluA2, mGluR7 and the dopamine transporter with no apparent con-
served binding motif. The wide span of affinities seen for such proteins raises
the question of the importance of the affinity for the isolated domain interac-
tions in context of the overall avidity and the functional effects of these
interactions.
We have established a system based on the previously published supported
membrane sheet system to study the binding of PICK1 to a cell membrane ex-
pressed ligand to determine the avidity for ‘‘on membrane interactions’’. Sec-
ondly, we address the functional effects of lowering the affinity of the PDZ
domain interactions on the functional effects of PICK1.
We demonstrate a dramatic increase in the binding Kd for the oligomeric inter-
action compared to affinities previously reported in non-native condition bind-
ing assays. Furthermore, we show that the interaction is only facilitated by
functional PDZ domain. We also observe a significant change in Bmax for
lower affinity ligands indicating that the increase of the PDZ affinities might
rely on a cooperative binding mechanism of the PICK1 homodimer, which is
consistent with results showing that the homodimer binds tighter than the
monomer.
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A common challenge in biophysical studies of membrane proteins is the choice
of an adequate model membrane or membrane mimetic. Commonly used mi-
metics (detergents, liposomes) often suffer from well known limitations (ad-
verse modification of protein structure, inhomogeneous protein distribution,
etc.), thus prohibiting extensive studies on membrane proteins. However, the
recently developed ‘nanodisc’ membrane mimetic sytem has helped alleviate
some of these shortcomings. Nanodiscs are self assembled proteolipid particles,
wherein two copies of an apolipoprotein A-I derived recombinant membrane
scaffold protein (MSP) clasp a lipid patch, and seal the hydrophobic edge of
the bilayer from water. The incorporation of a membrane protein into the
558a Wednesday, February 6, 2013nanodiscs is accomplished by its addition to the initial lipid and MSP mixture.
Microscale thermophoresis (MST) is a recently developed technology that
studies interactions based on the differential movement of biomolecules and
their complexes in a microscopic temperature gradient. MST is highly sensi-
tive, since it depends on changes in the size, charge and hydration shell of mol-
ecules. It measures interactions in free solution (no coupling required) and
needs only very low sample volumes. It thus provides advantages over existing
techniques like fluorescence correlation spectroscopy (FCS), isothermal titra-
tion calorimetry (ITC) and surface plasmon resonance (SPR). The use of nano-
discs in MST-based interaction studies of membrane proteins with ligands, or
of lipid membranes with soluble peptides is very appealing. We thus explored
this approach experimentally. Potential pitfalls of the method (aggregation of
nanodiscs, undesired interactions with the capillary walls, etc.) were addressed
and ways to overcome such difficulties are presented. Finally, MST was suc-
cessfully applied for the measurement of binding affinities between various
membrane proteins and their ligands.
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Specific protein-protein interactions control many crucial processes of the liv-
ing cell. We aim at elucidating specificity of the interactions at the model sys-
tem of interferon gamma (IFNg) and its cellular receptor 1 (IFNgRec1), the
system important in innate immunity. To modulate (increase as well as de-
crease) specificity of the interaction we searched for mutations of the receptor
molecule that was subjected to in silico mutations using the crystallographi-
cally determined structures of IFNg/IFNgRec1 complex. Amino acid substitu-
tions were modeled by empirical force field implemented in the web-based
software FoldX. About twenty computer-selected candidate mutants of IFN-
gRec1 were successfully expressed in Escherichia coli, purified to homogeneity
and their affinities to IFNg were determined by surface plasmon resonance
(SPR). The SPR measurements showed that affinity of most receptor variants
designed for affinity increase had their affinity virtually unchanged, a few
had affinity slightly lower but a few bound with affinity significantly higher.
Simple and computationally cheap method was therefore able to predict in-
crease of affinity. The receptor variants with increased affinity may be used
for diagnostic purposes.
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Human ClC-5 is a Cl/Hþ antiporter belonging to the CLC family, which in-
cludes both Cl channels and Cl/Hþ antiporters. Small organic molecules
have been useful tools for studying ion channels and many commercial drugs
target specific ion channel proteins. Some blockers have been found to inhibit
the plasma membrane localized CLC channels ClC-0, ClC-1 and ClC-Ka.
However, high-affinity ligands for most CLCs are missing.
Here, we tested the benzofuran derivative RT-931,2 on ClC-5 and ClC-4. Inter-
estingly RT-93 inhibits ClC-5 (EC50 ~ 200 mM), but has only a small effect on
the highly homologous antiporter ClC-4. Towards our goal to identify the bind-
ing site of RT-93 on ClC-5, we constructed 12 chimeras between ClC-4 and
ClC-5. Guided by the crystal structure of a bacterial CLC protein and using
the alignment between ClC-4 and ClC-5, we identified the sequence stretches
with the main differences between these two proteins and substituted in ClC-
5 the portions with the corresponding sequence of ClC-4. We expect to remove
the RT-93 sensitivity at least in one of these. So far we tested 8 chimeras, none
of which, however, showed a significant difference in comparison with ClC-5.
If none of the chimeras eliminates the binding site we will proceed with con-
structing larger chimeras.
Discovering the binding site of this blocker might help in creating a more effi-
cient ligand that, apart from being a useful biophysical tool, may provide a way
to modulate protein function in vivo.
(Supported by PRIN, Telethon (GGP08064; GGP12008) and IIT).
1. Liantonio et al. 2008. PNAS
2. Liantonio et al. 2012. J Hypertens.2865-Pos Board B20
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The origin of many disease states has been linked to genetic mutations, defects
in gene expression, nuclear excision repair and ribosome biogenesis. Centrin,
a calcium binding protein, which has recently been found to regulate some
of these processes along other target proteins within the nucleus. One target,
Krr1, contains a K homology (KH) domain; which has been identified as a nu-
cleic acid recognition motif, required for proper processing of pre-rRNA, for
synthesis of 18S rRNA, and for the assembly of the 40S subunit. Our initial
findings have identified a putative centrin binding site located within the KH
domain of Krr1 using bioinformatics tools. In this study, the KH domain
(192 bp) was amplified by PCR and then ligated to the expression vector
pET100. Colony PCR was performed to identify the E. coli colonies that
have been transformed effectively with the desired recombinant. The Krr1
KH domain fragment was then overexpressed. An isolation and purification
protocol has been designed which includes preparative centrifugation, cross
flow and tangential flow filtration and two ion exchange chromatography.
The evaluation of the purification of the KH domain fragment has been per-
formed by SDS-PAGE and peptide samples have been sent for MS analysis
and partial amino acid sequencing.
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Mesothelin is a cell surface protein that is normally found in mesothelial cells
lining the pleura, pericardium and peritoneum, but is aberrantly expressed at
high level in a variety of cancers including mesothelioma, ovarian, pancreatic
and lung cancers. Although the physiological function of mesothelin is unclear,
studies have shown that it is capable of binding to the tumor antigen CA-125
(also known as MUC16), leading to cell adhesion and tumor metastasis. Since
mesothelin is specifically expressed at a significantly higher level in malignant
tumors, development of an antibody against mesothelin is therefore of major
importance in the field of cancer therapy. MORAb-009 is a humanized mono-
clonal antibody against mesothelin currently under clinical trials. Animal ex-
periments have shown that application of MORAb-009 in combination with
chemotherapy leads to a marked reduction in tumor growth of mesothelin-
expressing tumors.
We show here that MORAb-009 recognizes a non-linear epitope that is con-
tained in the first 64-residue fragment of the mesothelin. We further demon-
strate that the recognition is sensitive to the loss of a disulfide bond linking
residues Cys7 and Cys31. The crystal structure of the complex between the
mesothelin N-terminal fragment and Fab of MORAb-009 at 2.6 A˚ resolution
reveals an epitope encompassing multiple secondary structural elements of
the mesothelin, The mesothelin fragment has a compact, right-handed superhe-
lix structure consisting of five short helices and connecting loops. A residue es-
sential for complex formation has been identified as Phe22, which projects its
side chain into a hydrophobic niche formed on the antibody’s recognition sur-
face upon antigen-antibody contact. The overlapping binding footprints of both
the monoclonal antibody and the cancer antigen CA125 explains the therapeu-
tic effect and provides a basis for further antibody improvement.
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A series of [(2-pyrimidinylthio)acetyl]benzenesulfonamides were designed
and synthesized. their binding affinities as inhibitors of several recombinant
human carbonic anhydrase (CA) isozymes were determined by isothermal
titration calorimetry and thermal shift assay yielding intrinsic Gibbs free en-
ergies, enthalpies, entropies, and heat capacities of binding. A group of com-
pounds containing a chlorine atom in the benzenesulfonamide ring were found
to exhibit higher selectivity but lower binding affinity toward tested CAs. The
crystal structures of selected compounds in complex with several CAs were
determined and the docking studies were performed to compare the binding
